A world-first clinical trial has been launched at Sydney Children’s Hospital, Randwick for children with ependymoma – a rare and devastating form of paediatric brain cancer.

The Deflexifol® At Relapse Trial (DART), proudly supported by Kids with Cancer Foundation, is being led by Professor David Ziegler and Dr Marion Mateos at the Kids Cancer Centre (KCC) and will test Deflexifol® - a new Australian-developed co-formulation of a chemotherapy called...read more.